Changeflow GovPing Healthcare Appointment of Senior Executive Service Perform...
Routine Notice Added Final

Appointment of Senior Executive Service Performance Review Board Members

Favicon for www.federalregister.gov FR: Office of National Drug Control Policy
Published March 6th, 2025
Detected March 14th, 2026
Email

Summary

The Office of National Drug Control Policy has published a notice announcing the appointment of members to its Senior Executive Service Performance Review Board. This action is part of the agency's internal administrative processes for evaluating executive performance.

What changed

This notice from the Office of National Drug Control Policy (ONDCP) announces the appointment of members to its Senior Executive Service (SES) Performance Review Board. The ONDCP is part of the Executive Office of the President. This is an administrative action related to the internal functioning and oversight of SES employees within the agency.

This notice is primarily informational and does not impose new obligations or requirements on external entities. Compliance officers should note this as an update to government agency operations. No specific actions are required from regulated entities, and there are no associated compliance deadlines or penalties mentioned.

Source document (simplified)

Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

Appointment of Members of Senior Executive Service Performance Review Board

A Notice by the Office of National Drug Control Policy on 03/06/2025

  • 1.

1.

Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data

- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2025-03572 Email Email this document to a friend Enhanced Content - Sharing

  • Print Enhanced Content - Print
  • Document Statistics Enhanced Content - Document Statistics Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.

Page views 281
as of
03/14/2026 at 2:15 pm EDT Enhanced Content - Document Statistics
- Other Formats Enhanced Content - Other Formats This document is also available in the following formats:

JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2025-03572 as it appeared on Public Inspection on
03/05/2025 at 8:45 am.

It was viewed
6
times while on Public Inspection.

If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.

Public Inspection
Published Document: 2025-03572 (90 FR 11440) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings Document headings vary by document type but may contain
the following:

  1. the agency or agencies that issued and signed a document
  2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  3. the agency docket number / agency internal file number
  4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.
Executive Office of the President
Office of National Drug Control Policy

AGENCY:

Office of National Drug Control Policy (ONDCP), Executive Office of The President.

ACTION:

Notice of appointments.

SUMMARY:

The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Ms. Martha Gagné (as Chair), Ms. Debbie Seguin, Ms. Tilda Farhat, and Ms. Kelly George.

FOR FURTHER INFORMATION CONTACT:

Please direct any questions to Anthony Jones, Acting General Counsel, (202) 881-8862, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503.

Authority: 5 U.S.C. 4314(c)(1).

Dated: February 28, 2025.

Anthony Jones,

Acting General Counsel.

[FR Doc. 2025-03572 Filed 3-5-25; 8:45 am]

BILLING CODE 3280-F5-P

Published Document: 2025-03572 (90 FR 11440)

Classification

Agency
FR
Published
March 6th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Government agencies
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Government Operations Personnel Management

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FR: Office of National Drug Control Policy publishes new changes.

Free. Unsubscribe anytime.